Skip to main content
Premium Trial:

Request an Annual Quote

Irene Hrusovsky, Gary Alianell, James Prudent

Premium

Bioinformatics and nucleic acid design startup EraGen Biosciences of Madison, Wisc., has named Irene Hrusovsky as its president and chief executive officer. Hrusovsky comes to EraGen from GlaxoSmithKline, where she served as vice president of general medicine/medical marketing strategy/clinical operations. Previously, Hrusovsky worked for over 20 years at Abbott Laboratories in diagnostics, pharmaceuticals, and business development management positions. Hrusovsky, who is a board-certified pediatrician, received her MD at the University of British Columbia, and her pediatric training at Ohio State University.

Hrusovsky joins an executive team made of chief operating officer Gary Alianell, who holds a PhD in molecular genetics from the University of South Carolina, and chief scientific officer James Prudent, the co-inventor of Third Wave’s Invader technology.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.